Cargando…
AnaConDa Device: Solution to Perform Cardiac Surgery Without Intravenous Anesthetic During the Corona Virus Disease 2019 Pandemic
Autores principales: | Labaste, François, Rey, Valentin, Gonzalez, Hélène, Marcheix, Bertrand, Fourcade, Olivier, Minville, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760556/ https://www.ncbi.nlm.nih.gov/pubmed/33082095 http://dx.doi.org/10.1053/j.jvca.2020.09.121 |
Ejemplares similares
-
Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice
por: Marcos-Vidal, Jose Miguel, et al.
Publicado: (2019) -
In Reply to “Letter to the Editor: AnaConDa Device: Solution to Perform Cardiac Surgery Without Intravenous Anesthetic During the Coronavirus Disease 2019 Pandemic”
por: Kermad, Azzeddine, et al.
Publicado: (2021) -
In vitro performance evaluation of AnaConDa(TM)-100 and AnaConDa(TM)-50 compared to a circle breathing system for control and consumption of volatile anaesthetics
por: Bellgardt, Martin, et al.
Publicado: (2020) -
Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics
por: Iwasaki, Yudai, et al.
Publicado: (2022) -
Sevoflurane Sedation with AnaConDa-S Device for a Child Undergoing Extracorporeal Membrane Oxygenation
por: Soreze, Yohan, et al.
Publicado: (2020)